SWX:LONN - アナリストの将来予測と過去の財務データ ( )CHF Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2026	8,623	1,377	433	2,039	13
12/31/2025	7,688	1,126	438	1,681	13
12/31/2024	6,682	829	-174	1,513	14
6/30/2024	6,696	573	-30	1,524	N/A
3/31/2024	6,707	614	-169	1,456	N/A
12/31/2023	6,717	654	-309	1,388	N/A
9/30/2023	6,518	892	-532	1,239	N/A
6/30/2023	6,319	1,129	-756	1,089	N/A
3/31/2023	6,271	1,172	-828	1,055	N/A
12/31/2022	6,223	1,215	-901	1,020	N/A
9/30/2022	6,036	1,062	-819	994	N/A
6/30/2022	5,849	909	-737	968	N/A
3/31/2022	5,629	792	-450	1,093	N/A
12/31/2021	5,409	674	-163	1,217	N/A
9/30/2021	5,108	612	-2	1,233	N/A
6/30/2021	4,807	550	159	1,249	N/A
3/31/2021	4,658	640	150	1,190	N/A
12/31/2020	4,508	730	140	1,130	N/A
9/30/2020	3,135	656	236	1,181	N/A
6/30/2020	3,474	696	344	1,241	N/A
3/31/2020	3,841	672	266	1,109	N/A
12/31/2019	4,207	647	188	977	N/A
9/30/2019	5,821	710	N/A	N/A	N/A
6/30/2019	5,722	658	117	821	N/A
3/31/2019	5,632	657	312	952	N/A
12/31/2018	5,542	655	506	1,082	N/A
6/30/2018	5,034	826	378	860	N/A
3/31/2018	4,791	745	N/A	851	N/A
12/31/2017	4,548	664	N/A	841	N/A
9/30/2017	4,758	527	N/A	798	N/A
6/30/2017	4,423	334	N/A	738	N/A
3/31/2017	4,278	318	N/A	745	N/A
12/31/2016	4,132	301	N/A	752	N/A
9/30/2016	4,025	331	N/A	779	N/A
6/30/2016	3,918	360	N/A	805	N/A
3/31/2016	3,861	319	N/A	773	N/A
12/31/2015	3,803	277	N/A	741	N/A
9/30/2015	3,774	243	N/A	710	N/A
6/30/2015	3,744	208	N/A	678	N/A
3/31/2015	3,692	223	N/A	581	N/A
12/31/2014	3,640	237	N/A	483	N/A
9/30/2014	3,640	212	N/A	534	N/A
6/30/2014	3,640	186	N/A	584	N/A
3/31/2014	3,612	137	N/A	553	N/A
12/31/2013	3,584	87	N/A	522	N/A

アナリストによる今後の成長予測

収入対貯蓄率: LONNの予測収益成長率 (年間20.6% ) は貯蓄率 ( 0.2% ) を上回っています。

収益対市場: LONNの収益 ( 20.6% ) はSwiss市場 ( 8.2% ) よりも速いペースで成長すると予測されています。

高成長収益: LONNの収益は今後 3 年間で大幅に増加すると予想されています。

収益対市場: LONNの収益 ( 11.4% ) Swiss市場 ( 4.4% ) よりも速いペースで成長すると予測されています。

高い収益成長: LONNの収益 ( 11.4% ) 20%よりも低い成長が予測されています。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: LONNの自己資本利益率は、3年後には低くなると予測されています ( 13.4 %)。

Lonza Group 将来の成長

Future 基準チェック /46

主要情報

今後の成長に関する最新情報

Price target increased by 7.3% to CHF503

Price target decreased by 8.9% to CHF463

Price target decreased by 8.4% to CHF539

Price target decreased by 8.5% to CHF569

Lonza Group AG Provides Sales Guidance for the Year 2023

Consensus EPS estimates fall by 12%

Recent updates

Lonza Group AG (VTX:LONN) Not Flying Under The Radar

First half 2024 earnings: EPS in line with analyst expectations despite revenue beat

Now 20% overvalued after recent price rise

Lonza Group AG to Report Fiscal Year 2024 Results on Jan 30, 2025

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Lonza Group AG's (VTX:LONN) Share Price Matching Investor Opinion

Lonza Group AG Approves Cash Dividend, Payable on May 15, 2024

Some Investors May Be Willing To Look Past Lonza Group's (VTX:LONN) Soft Earnings

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Dividend increased to CHF4.00

Now 21% undervalued

Lonza Group AG Announces Chief Executive Officer Changes

Estimating The Intrinsic Value Of Lonza Group AG (VTX:LONN)

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Now 20% undervalued

Lonza Group AG (VTX:LONN) Looks Just Right With A 25% Price Jump

Price target increased by 7.3% to CHF503

Lonza Group AG to Report First Half, 2024 Results on Jul 25, 2024

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Lonza Group AG to Report Fiscal Year 2023 Results on Jan 26, 2024

Lonza Group AG, Annual General Meeting, May 08, 2024

Price target decreased by 8.9% to CHF463

Calculating The Intrinsic Value Of Lonza Group AG (VTX:LONN)

Is Lonza Group (VTX:LONN) A Risky Investment?

Price target decreased by 8.4% to CHF539

Price target decreased by 8.5% to CHF569

Investor sentiment deteriorates as stock falls 17%

Lonza Group AG Provides Sales Guidance for the Year 2023

Now 24% undervalued after recent price drop

Lonza Group AG Announces CEO Changes

A Look At The Fair Value Of Lonza Group AG (VTX:LONN)

Consensus EPS estimates fall by 12%

Lonza Group AG Just Missed EPS By 11%: Here's What Analysts Think Will Happen Next

New minor risk - Share price stability

First half 2023 earnings: EPS and revenues miss analyst expectations

Lonza Group (VTX:LONN) Has A Pretty Healthy Balance Sheet

Lonza Group AG (SWX:LONN) acquired Synaffix BV.

Lonza Group AG (SWX:LONN) acquired Synaffix BV.

With EPS Growth And More, Lonza Group (VTX:LONN) Makes An Interesting Case

Lonza Group AG Reiterates Sales Guidance for the Years 2023

Upcoming dividend of CHF3.50 per share at 0.6% yield

These 4 Measures Indicate That Lonza Group (VTX:LONN) Is Using Debt Reasonably Well

Full year 2022 earnings: EPS exceeds analyst expectations

If EPS Growth Is Important To You, Lonza Group (VTX:LONN) Presents An Opportunity

Lonza Group AG to Report First Half, 2023 Results on Jul 21, 2023

Full year 2022 earnings: EPS exceeds analyst expectations

Lonza Group AG Provides Earnings Guidance for the Year 2023

Lonza Group AG (SWX:LONN) announces an Equity Buyback for CHF 2,000 million worth of its shares.

Lonza Group AG, Annual General Meeting, May 05, 2023

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Is Now The Time To Put Lonza Group (VTX:LONN) On Your Watchlist?

Lonza Group (VTX:LONN) Seems To Use Debt Quite Sensibly

Lonza Appoints Daniel Palmacci as President of the Cell & Gene Division, Effective from November 1, 2022

Do Lonza Group's (VTX:LONN) Earnings Warrant Your Attention?

First half 2022 earnings released

Lonza Group AG Reconfirms Sales Guidance for the Years 2022 and 2024

Lonza Group Announces Management Changes, Effective August 1, 2022

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Upcoming dividend of CHF3.00 per share

Insufficient new directors

Sigma-Aldrich Corporation acquired Modular Automated Sampling Technology Platform of Lonza Group AG.

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Lonza Group Ltd. Announces Sales Guidance for the Full-Year 2022

Insufficient new directors

Does Lonza Group (VTX:LONN) Have A Healthy Balance Sheet?

Lonza and Triumvira Immunologics Announces First Patient with HER2-overexpressing Cancer Dosed with TAC-T Cell Therapy Using the Lonza Cocoon Platform

Lonza Group (VTX:LONN) Has A Somewhat Strained Balance Sheet

Lonza Group Ltd Provides Earnings Guidance for the Year 2021

First half 2021 earnings released: EPS CHF3.51 (vs CHF5.94 in 1H 2020)